DrB

Call Directions Website Contact the business

DrB Proudly of Moroccan heritage which I bring into personal & professional life. As a pulmonary/critical care doc, I’m passionate about AI/healthcare.

I simplify AI for colleagues so it’s accessible & practical. Let’s bridge medicine and technology together!

Heading back to Morocco to teach! 🇲🇦I'll be leading pulmonology sessions and AI & digital health sessions for medical st...
10/24/2026

Heading back to Morocco to teach! 🇲🇦

I'll be leading pulmonology sessions and AI & digital health sessions for medical students, and I'm so excited.

Confession: I spent days preparing for a rainy week. Then I realized my weather app was set to Marrakesh. 😅 The real forecast: moderate, lovely fall temperatures. The rain gear is staying home.

This trip is also tender for me. It's my first visit to Morocco since my dad said goodbye. I'm looking forward to visiting him and paying my respects. 🤍

Raul Fortunet, Nina Maouelainin, Lamya Chrif Morand, Hicham Skalli, Mounir Mikou

In one October week, America's largest banks drew a line on AI agents, and regulators started asking hard questions.Per ...
10/23/2026

In one October week, America's largest banks drew a line on AI agents, and regulators started asking hard questions.

Per Reuters, the Fed, OCC and FDIC asked banks six things about their AI systems. Swap "bank" for "hospital" and they read like a checklist for every health system bringing agents into the EHR:

1. What is this agent allowed to touch?
2. Who reviews and approves its work?
3. Can we reconstruct what it did?
4. What keeps it inside its privileges?
5. Where must a clinician sign off?
6. Who can switch it off, and how fast?

The hopeful part: banks didn't reject agents. BNY runs about 140 "digital employees" with their own credentials and a human manager. What the banks rejected was anonymous agents wearing a human's identity.

These are questions medicine already knows how to answer. Verify identity, define scope, supervise, document, and expand privileges as trust is earned. It's how we train residents.

Which of the six is your organization still working on?

Full article on Substack: https://theaireadydoctor.substack.com/p/the-agent-will-see-you-now-what-banks

We made the Top 15, and I'm currently 1st in my group! 🎙️ Thank you to everyone who voted.I'm a doctor who speaks AI flu...
10/23/2026

We made the Top 15, and I'm currently 1st in my group! 🎙️ Thank you to everyone who voted.

I'm a doctor who speaks AI fluently, and I want to bring the ICU bedside to everyone this technology touches: caregivers, nurses, students, physicians and patients. Not hype, not fear. Just the honest question of what AI does to the humans giving and receiving care.

The prize is a six-episode iHeartRadio podcast and a guest spot on On Air with Ryan Seacrest.

Voting for the Top 10 ends Thursday, Oct 29 at 7 PM PT. You can vote once a day. 💙
👉 tophost.org/2026/hassan-bencheqroun-md

Subpleural lesion? The guidance tool may matter as much as the needle. 🫁A new randomized trial in CHEST (Bi K et al., pu...
10/23/2026

Subpleural lesion? The guidance tool may matter as much as the needle. 🫁

A new randomized trial in CHEST (Bi K et al., published online Oct 3, 2026) randomized 2,485 patients at 4 centers to percutaneous biopsy guided by contrast-enhanced ultrasound (CEUS), plain ultrasound or CT.

CEUS in brief: ultrasound plus an IV microbubble contrast agent. It shows which parts of a lesion have blood flow, so the needle can aim at viable tissue instead of necrosis.

• Diagnostic yield (strict ATS/CHEST definition): CEUS 88.8% vs CT 78.9% vs plain US 76.0%
• Complications: CEUS 4.6% vs plain US 7.5% vs CT 15.8%

Caveats: all four centers are in one country and have deep ultrasound expertise, so this may not carry over to every program yet.

For my IP and pleural colleagues: would this change your pathway for pleural-based lesions?

https://doi.org/10.1016/j.chest.2026.09.089



American College of Chest Physicians

Rapid fire, real data. 🫁⚡At in Phoenix, I presented "Self-Reported Asthma Prescription Behaviors" in Rapid Fire Area 1...
10/22/2026

Rapid fire, real data. 🫁⚡

At in Phoenix, I presented "Self-Reported Asthma Prescription Behaviors" in Rapid Fire Area 1B: 370 responses from clinicians in 48 countries on how they choose biologics, when they reassess, and why they switch.

What stood out to me:
• Omalizumab was the most often reported first biologic (32%), followed by mepolizumab (25%), benralizumab (24%) and dupilumab (19%), with real differences across regions.
• Switching is common, and some clinicians are already combining biologics.
• These are self-reported patterns, not proof that one biologic beats another. They show where practice varies and where we still need better evidence.

Thank you to my IQVIA collaborators, to CHEST for the stage, and to everyone who stayed after to keep the conversation going. 💙

P.S. Tezepelumab is gaining traction, but when we closed the survey for our CHEST submission there weren't yet enough responses to analyze it. Next year? 👀


American College of Chest Physicians

Saadia Faiz, thank you for the moments we shared at in Phoenix, for the hugs, and for your prayers. The Al-Fatiha and ...
10/22/2026

Saadia Faiz, thank you for the moments we shared at in Phoenix, for the hugs, and for your prayers. The Al-Fatiha and Surah Yaseen you read will stay with me. 💙

I can't wait to share meaningful work alongside you moving forward.

After ghosting me online for a few weeks, the queen finally deigned to talk to me at in Phoenix. 😂👑Neha, congratulatio...
10/22/2026

After ghosting me online for a few weeks, the queen finally deigned to talk to me at in Phoenix. 😂👑

Neha, congratulations to you both on the angel who just joined your family. 💙 And Harpreet, it was so great to finally meet you!

Neha, I can't wait to invite you to join Navitha Ramesh and me at in Los Angeles to talk about the future of the neuro ICU. 🧠 Here's where that conversation started at Neurotech 2026: https://www.linkedin.com/posts/medicalaiacademy_aiinhealthcare-neuroicu-digitaltwins-activity-7451770230483189760-8jHA


Society for Brain Mapping & Therapeutics

10/21/2026

Years ago, Jaswinder Kaur, MD and I rounded together on tele-ICU patients when she was a PGY1. Today she's a critical care fellow, and at in Phoenix she showed me something she built herself: a high-fidelity simulator that teaches residents how to manage noninvasive ventilation, from working out the type of respiratory failure in a COPD exacerbation to troubleshooting patient-ventilator asynchrony on BiPAP.

She grounded it in the PubMed literature on noninvasive ventilation and respiratory therapist training, and taught herself Google Colab, BigQuery and ChatGPT to build it.

AI, critical care, education and brilliance, all in one. This is one of those moments when the learner surpasses the teacher.

I'm so impressed, and I continue to have faith in the next generation and in AI. They'll prove us wrong and show AI doing a lot of good for our patients.



American College of Chest Physicians

As promised: you asked, we answer.Thank you to everyone who joined our COPD Without Walls panel at , and to my co-panel...
10/21/2026

As promised: you asked, we answer.

Thank you to everyone who joined our COPD Without Walls panel at , and to my co-panelists Dr. Lakshman Swamy and Dr. Alejandra Lastra with American College of Chest Physicians. Swipe through for answers to your Q&A for this session on home-based COPD care.

What's your biggest barrier to home-based COPD care? Tell me below.

Address

San Diego, CA
92117

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+17606181353

Website

Alerts

Be the first to know and let us send you an email when DrB posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to DrB:

Shortcuts

Sponsored

Share